Cargando…
Mucormycosis coinfection post-COVID-19 recovery: Early suspicion and prompt action
Severe acute respiratory syndrome coronavirus 2 infection has resulted in a pandemic, the disease manifests itself as various conditions ranging from respiratory disorders to exacerbated inflammatory responses. The management in some cases involves immediate care in an intensive setup with the admin...
Autores principales: | Kulkarni, Vishal, Kumar, C. Senthil, Misra, CS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651213/ https://www.ncbi.nlm.nih.gov/pubmed/36393958 http://dx.doi.org/10.4103/njms.NJMS_289_20 |
Ejemplares similares
-
COVID-19 and Mucormycosis Coinfection: How Challenging It Is
por: Nayak, Niranjan, et al.
Publicado: (2022) -
COVID-19 Coinfection With Mucormycosis in a Diabetic Patient
por: R, Roopa, et al.
Publicado: (2021) -
Disseminated tuberculosis and gastric mucormycosis coinfection
por: Malek, Alexandre, et al.
Publicado: (2019) -
Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021) -
Frontal osteomyelitis post-COVID-19 associated mucormycosis
por: Kulkarni, Pooja, et al.
Publicado: (2023)